Cafepharma.com
The NY Times with a profile. Unsurprisingly, they lack corporate support:
Not surprisingly, Cafepharma lacks corporate fans.
Pfizer, the subject of the site’s most popular bulletin board, declined repeated requests to discuss Cafepharma. Shreya Prudlo, a spokeswoman, said that Pfizer monitored every “communication channel” that reached its constituency, and that each needed to be “viewed based on their accuracy and integrity.”
Medtronic, which has the busiest Cafepharma …